Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable POZ lipids to replace current ionizable lipids for the ...

According to MarketsandMarkets(TM), the Next Generation Drug Conjugates Market is projected to grow from about USD 15.75 billion in 2026 to USD 42.55 billion by 2035, at a CAGR of 11.7%. Browse 260 ...

According to MarketsandMarkets™, the Next Generation Drug Conjugates Market is projected to grow from about USD 15.75 billion ...

Researchers at the University of Bristol have caught DNA-copying enzymes generating long stretches of genetic code without ...

New agreements expand access to in-lab DNA synthesis, enabling faster, on-demand oligonucleotide production, reducing ...

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co ...

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community. Researchers at Yonsei University in Seoul, South Korea, have published findings that outline ...

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flexibility across targeted and whole genome ...

The successful application of RNA therapies to rare diseases, neurological disorders, and other conditions as well as the plethora of biopharmaceutical companies developing new RNA-based therapeutics, ...

REDWOOD CITY, Calif., Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of ...